PolySearch2 - Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study.

PolySearch2 - Result Details

(2016) Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study. Central European journal of public health;Cent. Eur. J. Public Health;2016 12;24(4):297-301

MEDLINE 28095285 : Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study.

Back to View Evidence Back to View Results View Article on PubMed

Legend

Query Term

Association Word

Drug, Toxin

Gene, Protein, Gene Family, Pathway, SNP

Human Metabolite, Food Metaboilte, MeSH Compound

Tissue, Organ, Subcellular Localization

MeSH Term, Gene Ontology, Chemical Taxonomy, ICD-10 Code

Health Effect, Drug Effect, Adverse Effect

Disease, Species

Please cite:

Liu Y., Liang Y., Wishart D.S. (2015) PolySearch 2.0: A significantly improved text-mining system for discovering associations between human diseases, genes, drugs, metabolites, toxins, and more. Nucleic Acids Res. 2015 Jul 1;43(Web Server Issue):W535-42.

To cite the original version of PolySearch (no longer active), please cite:

Cheng D., Knox C., Young N., Stothard P., Damaraju S., Wishart D.S. (2008) PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res. 2008 Jul 1;36(Web Server Issue):W399-405.

This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $900 million in funding from the federal government.